Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 5 from PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
  1. Home
  2. Publications
  3. Supplementary Table 5 from PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors

Supplementary Table 5 from PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors

Authors:
  • SASherif Abdelhamed
    Sherif Abdelhamed
  • XZXinqun Zhang
    Xinqun Zhang
  • WZWeiping Zeng
    Weiping Zeng
  • BGBryan Grogan
    Bryan Grogan
  • LSLuke Schilperoort
    Luke Schilperoort
  • RJReice James
    Reice James
  • KBKelli C. Burley
    Kelli C. Burley
  • SSSamantha M. Sarrett
    Samantha M. Sarrett
  • LBLauren Bou
    Lauren Bou
  • PRParomita Raha
    Paromita Raha
  • DODevra J. Olson
    Devra J. Olson
  • HSHeather L. Sigurjonsson
    Heather L. Sigurjonsson

Open Access
Publisher website
Google Scholar
  • 2 July 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.29457007
Abstract
Percentage of Tumor Growth Inhibition (%TGI) for lymphoma xenografts.
Keywords
  • DRUG TARGETS
  • CELL SURFACE RECEPTOR DRUG TARGETS
  • IMMUNOLOGY
  • REGULATORY T CELLS
  • IMMUNOTHERAPY
  • ANTIBODY IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.